SCHEMBL21710467

SCHEMBL21710467

Cc1cc(C)cc(-c2cc3c4ccccc4n4c5cc6ccccc6cc5c(c2)c34)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 2/20 0.39
CYP1A2 P05177 1/20 0.39
NPY5R Q15761 3/20 0.35
KDM4E B2RXH2 5/20 0.35
HSD17B10 Q99714 5/20 0.35
ALDH1A1 P00352 4/20 0.35
HPGD P15428 3/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
RCE1 Q9Y256 1/20 0.35
TDP1 Q9NUW8 2/20 0.34
BRD9 Q9H8M2 1/20 0.34
BRD7 Q9NPI1 1/20 0.34
KMT2A Q03164 4/20 0.33
MEN1 O00255 3/20 0.33
MAPT P10636 3/20 0.33
GAA P10253 2/20 0.33
HTT P42858 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CHEK1 O14757 1/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19563765 0.94 CYP1A2 (0.39) CYP2A6CYP1A2NPY5RKDM4EALDH1A1
SCHEMBL21710648 0.91 CYP2A6 (0.43) CYP2A6CYP1A2NPY5RKDM4EHSD17B10
SCHEMBL21717345 0.89 BRD9 (0.40) CYP2A6CYP1A2KDM4EHSD17B10ALDH1A1
SCHEMBL21718144 0.89 CYP2A6 (0.37) CYP2A6CYP1A2NPY5RTDP1BRD9
SCHEMBL21717368 0.87 CYP2A6 (0.42) CYP2A6CYP1A2NPY5RKDM4EHSD17B10
SCHEMBL19563825 0.87 CYP2A6 (0.36) CYP2A6CYP1A2NPY5RKDM4EALDH1A1
SCHEMBL21717366 0.86 ESR1 (0.39) NPY5RKDM4EHSD17B10ALDH1A1HPGD
SCHEMBL21717822 0.85 ESR1 (0.38) NPY5RKDM4EHSD17B10ALDH1A1HPGD
SCHEMBL21718047 0.85 ESR1 (0.38) CYP1A2NPY5RKDM4EHSD17B10ALDH1A1
SCHEMBL19563800 0.84 CYP1A2 (0.44) CYP2A6CYP1A2KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11723272-B2 Organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-08-08 US disclosed
US-11723272-B2 Organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-08-08 US disclosed
US-20210005826-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO., LTD. (JP) 2021-01-07 US disclosed
US-20210005825-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2021-01-07 US disclosed
US-20200365812-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2020-11-19 US disclosed
US-20200052225-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2020-02-13 US disclosed
US-20200052212-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200052225-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE LEF1, L1CAM, ESR2 CYP2A6 3452/4885CYP1A2 1303/4885NPY5R 3775/4885
US-20210005825-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE OR51E2, CD99, CTNND1 CYP2A6 2475/4885CYP1A2 259/4885NPY5R 4059/4885
US-20210005826-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC APPARATUS EML4, EBPL, LEF1 CYP2A6 4056/4885CYP1A2 2052/4885NPY5R 4507/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.